Week 2: Overview of Hypothalamic-Pit regulation & Adrenal function Flashcards
1
Q
Primary dysfunction
A
-if abnormal level of a hormone arises from a dysfunction in the peripheral gland making the hormone
2
Q
Secondary dysfunction
A
- If the cause of the abnormal hormone level arises from a pathology in the pituitary, the hypothalamus, or elsewhere
- may see inappropriate relationship: e.g. if hormone from peripheral gland is abnormal and level of pituitary hormone promoting its release is in normal range.
3
Q
Organization of the adrenal gland
A
CORTEX 1. glomerulosa --mineralocorticoids -aldosterone 2. fasciculata-- glucocorticoids -cortisol 3. reticularis -androgens MEDULLA --catecholamines
4
Q
Adrenal medulla and catecholamines
A
- predominantly epinephrine (derived from tyrosine)
- released in response to sympathetic stimulation
- epinephrine have higher affinity for beta receptors, but response is based on tissue ratio of alpha and beta receptors
- physiological levels cause vasodilation, pharmacological can stimulate alpha receptors to cause vasocontriction
- also makes NE, but not significant. Nerve terminals are major source of NE.
5
Q
Synthesis of steroid hormones by adrenal cortex
A
- make from cholesterol
- C19 steroids are androgenic
- C21 steroids with 2-C chain attached to position 17 are glucocorticoids and mineralocorticoids
- adrenal gland doesn’t store steroid hormones, they are released soon after synthesis
6
Q
Adrenal androgens
A
- DHEA and androstenedione produced by zone reticularis
- have weak androgenic activity
- for females, peripheral conversion of these hormones to testosterone has effects (hirsutism)
- in males, testicular production of testosterone is much greater
7
Q
Adrenal mineralocorticoids
A
- AngII is major stimulator of synthesis and release of aldosterone
- secreted by zone glomerulosa.
- primary regulation through renin-angiotensin II-aldesoterone system and via K+ levels
8
Q
Adrenal glucocorticoids- circulation
A
- Cortisol and cortisone released from fasciculate zone of adrenal gland
- circulate bound to transcortin (a2 globulin)
- the free forms of hormones are active
9
Q
mechanisms determining specificity of glucocorticoid actiosn
A
- Type 1 receptors have mineralocorticoid actions
- Type 2 have glucocorticoid response
- Type 1 have equal affinity for cortisol and aldosterone
- 11b-hydroxy-steroid dehydrogenase converts cortisol and corticosterone but not aldosterone to forms (cortisone and 11-dehydrocorticosterone) that bind poorly to Type 1 and 2 receptors
- 11bHSD1: in most tissues, increases glucocorticoid action by converting cortisone to cortisol
- 11bHSD2: converts cortisol to cortisone in aldosterone target tissues such as kidney, colon, sweat glands
10
Q
Actions of glucocorticoids
A
- stimulation of gluconeogensis
- overall: catabolic and diabetogenic
- promotes storage of glucose in liver as glycogen during absorptive state
- increases protein catabolism in muscle, decreases new protein synthesis
- increases lipolysis, provides glycerol to liver
- decreases insulin sensitivity of adipose tissue
- essential for fasting and survival of stress - Anti-inflammatory effects
- induces synthesis of lipocortin, which inhibits phospholipase A2
- inhibits production of Il-2 and proliferation of T lymphocytes
- but can impede the walling off of infection - maintenance of vascular responsiveness to catecholamines
- lack of leads to capillary dilation and excessive permeability - Inhibition of bone formation
- increases GFR by vasodilation of afferent arterioles
- effects on CNS
11
Q
Regulation of cortisol secretion
A
- pulsatile release
- main regulator: pituitary ACTH (adrenocorticotropic hormone)
- ACTH increases adrenal cAMP
- controlled by negative feedback, inhibited by circulating steroids
- chronic Rx with GCs leads to ACTH suppression and atrophy of adrenal gland
- CRH stimulates ACTH release. negative feedback with cortisol.
12
Q
Cushing disease and syndrome
A
- syndrome: GC excess from any case
- disease: elevated ACTH e.g. from pituitary tumor
- possibly from activating mutations in cAMP dependent protein kinase
- HTN, muscle weakness, central obesity, fat in face and behind neck
- compromised collagen synthesis leading to striae